BridgeMD
Tests treatment safety and results for Halitosis
Official title Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
ClinicalTrials.gov ID: NCT06882564
What this study is testing
What is resveratrol mouthwash?
resveratrol mouthwash is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for halitosis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the study: To assess the efficacy of antioxidant (resveratrol) mouthwash in reducing the level of p. gingivitis and oral malodor over 7 day period among undergraduate dental student patients from Mustansiriyah University/College of Dentistry and Wasit University /College of Dentistry.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 24. Healthy volunteers may be eligible.
You may be able to join if
- Organoleptic tongue of scores \> 2 using (0-5scale) (Rosenberg and McCulloch, 1992)
- Male and female undergraduate dental students without chemical plaque control measures for at least one weak
- Male and female students with halitosis due to gingivitis
- The age of students ranges from 20 to 23 years.
- No periodontal treatment for at least one month
You likely can't join if
- Smokers and alcoholics
- Patient with periodontitis or pocket depth \> 6mm
- Patient with orthodontics appliance
- Open carious lesions, pericoronitis, dry socket, and fistula.
- Patients with systemic disease and condition
- taking medication in the last two weeks
See the full eligibility criteria
- Organoleptic tongue of scores \> 2 using (0-5scale) (Rosenberg and McCulloch, 1992)
- Male and female undergraduate dental students without chemical plaque control measures for at least one weak
- Male and female students with halitosis due to gingivitis
- The age of students ranges from 20 to 23 years.
- No periodontal treatment for at least one month
- No systemic disease
- No tobacco smoking
- The patients must have at least 20 teeth
- Smokers and alcoholics
- Patient with periodontitis or pocket depth \> 6mm
- Patient with orthodontics appliance
- Open carious lesions, pericoronitis, dry socket, and fistula.
- Patients with systemic disease and condition
- taking medication in the last two weeks
- Take garlic, onion, or licorice in the last 24 hours
- using oral hygiene products in the last 24 hours
- pregnant women
- sinusitis, tonsilitis, and upper respiratory tract infection
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Bab Al-Moadham, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 24 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Bab Al-Moadham, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.